The overall tone indicates cautious optimism, with comments highlighting the study's findings of favipiravir's efficacy, such as shorter viral clearance times and better chest improvements, while also raising questions about study design and timing of administration. Words like 'effective,' 'good news,' and references to clinical trials demonstrate a balanced tone combining interest and engagement, though some discussions mention its withdrawal or limitations, reflecting ongoing debates about its impact.
AgreementModerate agreement
Most discussions acknowledge positive findings for favipiravir, with some expressing cautious support and referencing clinical evidence.
InterestModerate interest
Participants show moderate interest, often asking about dosage, clinical relevance, and effectiveness, indicating active engagement with the research.
EngagementModerate engagement
Many social discussions delve into details like study methods, comparisons with other drugs, and mentions of clinical trials, reflecting thoughtful consideration.
ImpactModerate impact
The discussions suggest the publication may influence ongoing debates about COVID-19 treatments, with some references to regulatory approvals and withdrawals indicating notable impact.
Abstract in brief
This study evaluated the effectiveness of Favipiravir (FPV) compared to Lopinavir/Ritonavir (LPV/RTV) for treating COVID-19, showing that patients treated with FPV experienced faster viral clearance and more significant improvements in chest CT scans.
Patients receiving Favipiravir had a median viral clearance time of 4 days, significantly shorter than the 11 days for the control group, and also experienced fewer adverse events.
The findings suggest that Favipiravir may be a more effective and safer option for treating COVID-19 than the standard Lopinavir/Ritonavir therapy.]
Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejoría clínica por tomografía a los 14 días de tratamiento https://t.co/U9LlrAf2f9 https://t.co/tWIYepFdFo
Feb 2, 2021 · 42 likes · 22 shares · 1,963 followersView post →
I
influenzer
@influenzer3 · X
→ちなみに現時点で発表されている報告は2つ。
いずれも中国から。
催奇形性など安全性に懸念のある薬剤なだけに、しっかりとしたエビデンスが必要かと。
1) Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
https://t.co/YxgMbp9tIL
May 20, 2020 · 20 likes · 14 shares · 37,661 followersView post →
RC
Ronald M. Chavin
@rmchavin · X
5-13-2020: Good news from Russia for Avigan (favipiravir) for treating early COVID-19, confirming earlier studies in China and Japan:
https://t.co/KqZmxy1nqJ
https://t.co/eNrarWQHfS
https://t.co/cT6BFwqx4u
https://t.co/Os4Yauq8Vj
May 13, 2020 · 8 likes · 4 shares · 215 followersView post →
M無
Mugen UJIIE (氏家 無限)
@carpe_diem0820 · X
中国から報告され、一時撤回されていた「ファビピラビル（アビガン錠）」に関する論文が一部修正されて再掲載される
https://t.co/TPq9iGt5t0
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
https://t.co/0PfuJO7bJX
https://t.co/63CdToI6q2
Experimental treatment with favipiravir for COVID-19: an open-label control study
https://t.co/HAwmxYZ8rK
An open level non-randomized study comparing the effects of favipiravir (FPV) plus IFN-α by aerosol inhalation (n = 35) versus lopinavir/ritonavir (LPV/r) plus IFN-α
May 19, 2020 · 7 likes · 4 shares · 4,263 followersView post →
M無
Mugen UJIIE (氏家 無限)
@carpe_diem0820 · X
「アビガン」論文取り下げ 中国でのコロナ治療
https://t.co/0HGbDKAWtC
TEMPORARY REMOVAL: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
https://t.co/0PfuJO7bJX
https://t.co/epIBIPOQ4t
This video explains how to interpret scientific videos and verify information authenticity, focusing on a 2015 public study on Favipiravir (Avigan) and its potential for COVID-19 treatment, highlighting the importance…
This video explores the probable molecular mechanism of remdesivir in treating COVID-19, focusing on its potential to inhibit SARS-CoV-2 RNA synthesis. Further research is necessary to fully understand and enhance its…
Experimental Treatment with Favipiravir for COVID-19: An Open-label Control Study （2020, Volume 6, Issue 10）https://t.co/DlhIgl5IJi https://t.co/L4eS03Q0UF
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 20, 2021 · 22 shares · 3,434 followersView post →
P
__peroon3__
@peroon32 · X
COVID-19 に対する治療法は確立していない。本研究は COVID-19 の症例に対するファビピラビル. (favipiravir: FPV)とロピナビル(lopinavir: LPV)/ ...Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study https://t.co/Mdo9s04mZQ
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 6, 2021 · 22 shares · 3,349 followersView post →
M
Manuel
@asgonza_51 · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 6, 2021 · 22 shares · 1,824 followersView post →
PL
PC_Juan Andrés Lagos
@PC_JAL · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 6, 2021 · 22 shares · 25,670 followersView post →
RE
Rodrigo Espinoza
@RespinozaRojas · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 5, 2021 · 22 shares · 1,448 followersView post →
K
Kenof55
@eugeniofarias · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 4, 2021 · 22 shares · 4,064 followersView post →
C
Chris!
@ChrisComunista · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 4, 2021 · 22 shares · 804 followersView post →
R
Roberto
@antoniodigno · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 4, 2021 · 22 shares · 3,506 followersView post →
SM
Salvador MB
@SalvoMontalban6 · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 4, 2021 · 22 shares · 5,955 followersView post →
N
@NoteEquivoques
@SinTraidoras · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 3, 2021 · 22 shares · 4,083 followersView post →
MS
M. Angélica Sandoval
@Marisanru · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 3, 2021 · 22 shares · 1,903 followersView post →
OG
Oriel Gomez
@OrielGomez11 · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 3, 2021 · 22 shares · 3,103 followersView post →
GW
Guillermo Willy
@Guille_Capitan · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 3, 2021 · 22 shares · 2,645 followersView post →
A
AMAS
@nomastonteras · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 3, 2021 · 22 shares · 6,182 followersView post →
ÁC
Ándate CTM!
@Fusil_AK_47 · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 3, 2021 · 22 shares · 258 followersView post →
Y
yapen
@Menalkenun · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 3, 2021 · 22 shares · 379 followersView post →
J
Janorth
@cuarentero40 · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 3, 2021 · 22 shares · 2,526 followersView post →
LP
LOBA P.
@LobaP_ · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 3, 2021 · 22 shares · 3,761 followersView post →
R
Reddish
@reddish2 · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 3, 2021 · 22 shares · 4,333 followersView post →
G
Guayo
@guayoloayza · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 3, 2021 · 22 shares · 107 followersView post →
DJ
Daniel Jadue
@danieljadue · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 3, 2021 · 22 shares · 649,724 followersView post →
C
Cami
@babushkami · X
RT @solar_paula: Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejorí…
Feb 2, 2021 · 22 shares · 405 followersView post →
PO
Paula Solar Oliver
@solar_paula · X
Que dicen los estudios clínicos? Vamos de a uno, 1.-Pacientes tratados con favipiravir v/s LPV/RTV, mostraron mayor mejoría clínica por tomografía a los 14 días de tratamiento https://t.co/U9LlrAf2f9 https://t.co/tWIYepFdFo
Feb 2, 2021 · 42 likes · 22 shares · 1,963 followersView post →
E
Engineering
@EngineeringJrnl · X
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study https://t.co/DlhIgl5IJi #COVID19
Estudio 1: Q, Cai et al. “Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study” 16/04/20
“we conducted an open-label, nonrandomized, before-after controlled study in an isolation ward of The Third People’s Hospital of Shenzhen”
Fechas 30/01 a 14/02
Comentando sobre: https://t.co/rECK1PLi7U @EvelynComadre
Criticas
- No fue un estudio aleatorizado, fue en un único centro
- Los pacientes a los que les dieron FPV parecían estar menos enfermos por parametros clinicos.
- Los endpoints no fueron de relevancia clínica
https://t.co/3OgpTV94zu
the first favipiravir-based drug in the world approved for the treatment of COVID-19.
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
AFIFAVIR, buatan Rusia
May 21, 2020 · 1 like · 1 share · 768 followersView post →
石
石部統久
@mototchen · X
RT @influenzer3: →ちなみに現時点で発表されている報告は2つ。
いずれも中国から。
催奇形性など安全性に懸念のある薬剤なだけに、しっかりとしたエビデンスが必要かと。
1) Experimental Treatment with Favipiravir for C…
May 20, 2020 · 14 shares · 1,092 followersView post →
Y
Yoko
@yoko1_8_1 · X
RT @influenzer3: →ちなみに現時点で発表されている報告は2つ。
いずれも中国から。
催奇形性など安全性に懸念のある薬剤なだけに、しっかりとしたエビデンスが必要かと。
1) Experimental Treatment with Favipiravir for C…
May 20, 2020 · 14 shares · 1,421 followersView post →
内
内田
@uchida_kawasaki · X
RT @influenzer3: →ちなみに現時点で発表されている報告は2つ。
いずれも中国から。
催奇形性など安全性に懸念のある薬剤なだけに、しっかりとしたエビデンスが必要かと。
1) Experimental Treatment with Favipiravir for C…
May 20, 2020 · 14 shares · 1,928 followersView post →
I
ippatsu
@ippatsu_sendai · X
RT @influenzer3: →ちなみに現時点で発表されている報告は2つ。
いずれも中国から。
催奇形性など安全性に懸念のある薬剤なだけに、しっかりとしたエビデンスが必要かと。
1) Experimental Treatment with Favipiravir for C…
May 20, 2020 · 14 shares · 662 followersView post →
さT
さもありなん：TLほぼ追えてないぽんこつモードなう
@ikotto · X
RT @influenzer3: →ちなみに現時点で発表されている報告は2つ。
いずれも中国から。
催奇形性など安全性に懸念のある薬剤なだけに、しっかりとしたエビデンスが必要かと。
1) Experimental Treatment with Favipiravir for C…
May 20, 2020 · 14 shares · 354 followersView post →
こゆ
こくりこ☆ゆんぐる
@kokurikofufu · X
RT @influenzer3: →ちなみに現時点で発表されている報告は2つ。
いずれも中国から。
催奇形性など安全性に懸念のある薬剤なだけに、しっかりとしたエビデンスが必要かと。
1) Experimental Treatment with Favipiravir for C…
May 20, 2020 · 14 shares · 1,987 followersView post →
たF
たいしょー。“wanna get higher and further”
@fearless_TAISHO · X
RT @influenzer3: →ちなみに現時点で発表されている報告は2つ。
いずれも中国から。
催奇形性など安全性に懸念のある薬剤なだけに、しっかりとしたエビデンスが必要かと。
1) Experimental Treatment with Favipiravir for C…
May 20, 2020 · 14 shares · 1,363 followersView post →
す
すますと
@sumasto · X
RT @influenzer3: →ちなみに現時点で発表されている報告は2つ。
いずれも中国から。
催奇形性など安全性に懸念のある薬剤なだけに、しっかりとしたエビデンスが必要かと。
1) Experimental Treatment with Favipiravir for C…
May 20, 2020 · 14 shares · 328 followersView post →
C
chopperironman
@chopperironman · X
RT @influenzer3: →ちなみに現時点で発表されている報告は2つ。
いずれも中国から。
催奇形性など安全性に懸念のある薬剤なだけに、しっかりとしたエビデンスが必要かと。
1) Experimental Treatment with Favipiravir for C…
May 20, 2020 · 14 shares · 139 followersView post →
T
Tabatha
@araran100 · X
RT @influenzer3: →ちなみに現時点で発表されている報告は2つ。
いずれも中国から。
催奇形性など安全性に懸念のある薬剤なだけに、しっかりとしたエビデンスが必要かと。
1) Experimental Treatment with Favipiravir for C…
May 20, 2020 · 14 shares · 17,458 followersView post →
猛
猛損仙
@mosonsen · X
RT @influenzer3: →ちなみに現時点で発表されている報告は2つ。
いずれも中国から。
催奇形性など安全性に懸念のある薬剤なだけに、しっかりとしたエビデンスが必要かと。
1) Experimental Treatment with Favipiravir for C…
May 20, 2020 · 14 shares · 1,107 followersView post →
I
influenzer
@influenzer3 · X
→ちなみに現時点で発表されている報告は2つ。
いずれも中国から。
催奇形性など安全性に懸念のある薬剤なだけに、しっかりとしたエビデンスが必要かと。
1) Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
https://t.co/YxgMbp9tIL
May 20, 2020 · 20 likes · 14 shares · 37,661 followersView post →
RC
Ricardo Cabrera
@Ricabrera_MI · X
Does it seem to give hope? https://t.co/J0E2Juh3Ur https://t.co/4LgnKkJ6uc
RT @hichachu: Experimental treatment with favipiravir for COVID-19: an open-label control study
https://t.co/HAwmxYZ8rK
An open level non-r…
May 19, 2020 · 4 shares · 598 followersView post →
公愛
［公式］愛崎もえか
@mina_creamy0813 · X
RT @hichachu: Experimental treatment with favipiravir for COVID-19: an open-label control study
https://t.co/HAwmxYZ8rK
An open level non-r…
May 19, 2020 · 4 shares · 213 followersView post →
YG
yumi ＠gj
@ygjumi · X
RT @hichachu: Experimental treatment with favipiravir for COVID-19: an open-label control study
https://t.co/HAwmxYZ8rK
An open level non-r…
May 19, 2020 · 4 shares · 12,761 followersView post →
S
stl
@stlhykw · X
RT @hichachu: Experimental treatment with favipiravir for COVID-19: an open-label control study
https://t.co/HAwmxYZ8rK
An open level non-r…
May 19, 2020 · 4 shares · 633 followersView post →
ニ
ニューロドクター乱夢
@hichachu · X
Experimental treatment with favipiravir for COVID-19: an open-label control study
https://t.co/HAwmxYZ8rK
An open level non-randomized study comparing the effects of favipiravir (FPV) plus IFN-α by aerosol inhalation (n = 35) versus lopinavir/ritonavir (LPV/r) plus IFN-α
May 19, 2020 · 7 likes · 4 shares · 4,263 followersView post →
TS
The Brag Sheet
@sds69094560 · X
RT @rmchavin: 5-13-2020: Good news from Russia for Avigan (favipiravir) for treating early COVID-19, confirming earlier studies in China a…
RT @rmchavin: 5-13-2020: Good news from Russia for Avigan (favipiravir) for treating early COVID-19, confirming earlier studies in China a…
May 15, 2020 · 4 shares · 131 followersView post →
BK
Božena Kokot
@BoenaSvoabo · X
RT @rmchavin: 5-13-2020: Good news from Russia for Avigan (favipiravir) for treating early COVID-19, confirming earlier studies in China a…
May 15, 2020 · 4 shares · 3,510 followersView post →
RC
Ronald M. Chavin
@rmchavin · X
5-13-2020: Good news from Russia for Avigan (favipiravir) for treating early COVID-19, confirming earlier studies in China and Japan:
https://t.co/KqZmxy1nqJ
https://t.co/eNrarWQHfS
https://t.co/cT6BFwqx4u
https://t.co/Os4Yauq8Vj
May 13, 2020 · 8 likes · 4 shares · 215 followersView post →
RC
Ronald M. Chavin
@rmchavin · X
5-7-2020: Bad news from China plus the U.K. plus the U.S. for the extremely effective anti-HIV drug combo, Kaletra (lopinavir plus ritonavir), for treating COVID-19:
https://t.co/W1aGFHlRkw
https://t.co/KqZmxy1nqJ
https://t.co/yVwZJqDdsV
The favipiravir seems to be less effective if not administered within 7 days. - Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. https://t.co/EcVUVSVdzR https://t.co/ZgO6VzAZQj
Apr 29, 2020 · 1 like · 5,253 followersView post →
三財
三ツ沢ネオ/国債は借金ではありません。財務省をぶっ壊す!
@mzw_neo · X
RT @mzw_neo: @MqxPghDaHDid0gv 日本でこう言う治験が出来ないのだとしたら情けないですね。
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Co... https…
中国から報告され、一時撤回されていた「ファビピラビル（アビガン錠）」に関する論文が一部修正されて再掲載される
https://t.co/TPq9iGt5t0
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
https://t.co/0PfuJO7bJX
https://t.co/63CdToI6q2
A latest clinical study showing that #favipiravir has a certain effect in removing viruses from #COVID19 patients can be found here: https://t.co/UONayzynPI https://t.co/UPGY3taCdH
取り下げになって、また戻ってきた論文
無作為試験じゃないから、効果があるかは断定できない
しかし、アビガンの話から芸能人から出てしまったから、使いたいっていう人は増えるだろうな。。。
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Co... https://t.co/oXZlDxjbCv
#Avigan #Favipiravir
The first study from china has been revised and republished！
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study - ScienceDirect
https://t.co/kCamaDM9pH
Have a look at how MOH view Favipiravir:
https://t.co/WavXJSOZgM
Cai et al Experimental Treatment with Favipiravir for COVID-19: An Open-Label ControlStudy, Engineering (2020), doi: 10.1016/j.eng.2020.03.007
➡️Better chest improvement, shorter TTCR (80 participants) https://t.co/1cuFjlKh2F
アビガンニュース
撤回された深センの論文が訂正されて再掲されております。特に大きな問題はないようで、14日投与で有意差がついています。
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Co... https://t.co/VqSNIiYboR
Apr 16, 2020 · 1 like · 1 share · 2,065 followersView post →
え
えこさん
@CZc2a4jtEYQUuYw · X
RT @MalusPumila4: WITHDRAWN: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
https://t.co/RsskYYFZ3s
これがアビガンの取り下げになった論文か。
TEMPORARY REMOVAL: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study - ScienceDirect https://t.co/OKRMB1L1p6
@girlsfromrome 少し前にかなり回っていましたね。Gian Mario Migliaccio氏のこちらのヴィデオを見る価値があるかと思います。
DICIAMO BASTA! | Risposta aperta sul farmaco Avigan, Arbidol o virus creato in laboratorio!
https://t.co/W2AOPHa0Xa
「アビガン」論文取り下げ 中国でのコロナ治療
https://t.co/0HGbDKAWtC
TEMPORARY REMOVAL: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
https://t.co/0PfuJO7bJX
https://t.co/epIBIPOQ4t
@miyahara_itcons WITHDRAWN: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
https://t.co/LsbgHG73fq
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause.
取り下げ理由不明
RT @grawoig: Article: https://t.co/AzcjY62ZDs (OPEN)
"Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study" by…
Mar 29, 2020 · 3 shares · 3,159 followersView post →
A
ArroyoIvn
@ArroyoIvn · X
RT @grawoig: Article: https://t.co/AzcjY62ZDs (OPEN)
"Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study" by…
Mar 28, 2020 · 3 shares · 8,778 followersView post →
DD
Dave Grawoig, Ph.D.
@grawoig · X
RT @grawoig: Article: https://t.co/AzcjY62ZDs (OPEN)
"Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study" by…
Mar 28, 2020 · 3 shares · 6,541 followersView post →
DD
Dave Grawoig, Ph.D.
@grawoig · X
Article: https://t.co/AzcjY62ZDs (OPEN)
"Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study" by Qingxian Cai, Minghui Yang, Dongjing Liu, Jun Chen, Dan Shu, Junxia Xia, Xuejiao Liao, Yuanbo Gu, Qiue Cai, Yang Yang, Chenguang…https://t.co/XACDrCs9KI
Mar 28, 2020 · 5 likes · 3 shares · 6,541 followersView post →
AP
Ayebatonye Epemu, PhD
@A_tonye · X
RT @EngineeringCAE: A latest clinical study showing that favipiravir is effective and safe in the treatment of COVID-19, according to an En…
Mar 27, 2020 · 2 shares · 432 followersView post →
JC
José G. Arias Castellanos.
@Joscast21 · X
RT @Joscast21: Flavipiravir(FPV) superior a Lopinavir/Ritonavir(LPV/R), en el tratamiento del SARS-CoV 2❓
https://t.co/04OYnj0NH9 https://t…
A latest clinical study showing that favipiravir is effective and safe in the treatment of COVID-19, according to an Engineering paper. #COVID19 https://t.co/UONayzynPI https://t.co/4pX8gdC27n
Mar 18, 2020 · 2 shares · 225 followersView post →
farmacia Borgo Milano è la prima "Farmacia Amica dell'Allattamento Materno", un progetto nato da un'idea di Paolo Delaini e delle amiche ostetriche de "Il ...
PO
I
RC
M無
ニ
DK
E
DI
C
村英
磐年
り
Y日
辻コ
A
浜大
N
V
P
MT
M
PL
RE
K
C
R
SM
N
MS
OG
GW
A
ÁC
Y
J
LP
R
G
DJ
C
L
RV
RS
に
も
M
とカ
JO
き
K
BC
T
籠
灯
と夢
石
Y
内
I
さT
こゆ
たF
す
T
猛
RC
公愛
YG
S
TS
SB
BK
た
S
は独
徹
KM
三財
Iカ
ま
NS
YD
M
CS
NK
へ
旧
C
HS
森
LA
FB
MP
め
え
く
E
旅W
Y
く
は
EM
H
MM
う
S
茂M
BP
SK
མག
河
メ
な回
Y
無企
善
き
いか
MW
荒仮
蚊
AS
よ
L
AL
A
DD
AP
JC
S